Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Malone

Showing results (521-530 of 771) with videos related to

Pageof 78
Sort By:
Scientific Reports|May 28, 2024
Bioarchaeology aids the cultural understanding of six characters in search of their agency (Tarquinia, ninth-seventh century BC, central Italy)G Bagnasco, M Marzullo, C Cattaneo, et al.
Journal of the American Medical Informatics Association : JAMIA|April 2, 2015
Recommendations to improve the usability of drug-drug interaction clinical decision support alertsThomas H Payne, Lisa E Hines, Raymond C Chan, et al.
Plos One|April 14, 2021
Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415Rahul Khairnar, Stephanie L Pugh, Howard M Sandler, et al.
The Lancet. Oncology|September 8, 2018
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic reviewMadeline Pe, Lien Dorme, Corneel Coens, et al.
The Lancet. Oncology|February 3, 2020
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL ConsortiumCorneel Coens, Madeline Pe, Amylou C Dueck, et al.
Clinical Trials (London, England)|August 25, 2018
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trialsAndrew Bottomley, Madeline Pe, Jeff Sloan, et al.
The Lancet. Oncology|November 8, 2016
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standardsAndrew Bottomley, Madeline Pe, Jeff Sloan, et al.
Lancet (London, England)|May 19, 2024
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trialChris C Parker, Howard Kynaston, Adrian D Cook, et al.
Lancet (London, England)|May 19, 2024
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trialChris C Parker, Noel W Clarke, Adrian D Cook, et al.
JAMIA Open|August 4, 2021
Establishing a multidisciplinary initiative for interoperable electronic health record innovations at an academic medical centerKensaku Kawamoto, Polina V Kukhareva, Charlene Weir, et al.
Pageof 78

Showing results (521-530 of 771) with videos related to

Sort By:
Pageof 78
Scientific Reports|May 28, 2024
Bioarchaeology aids the cultural understanding of six characters in search of their agency (Tarquinia, ninth-seventh century BC, central Italy)G Bagnasco, M Marzullo, C Cattaneo, et al.
Journal of the American Medical Informatics Association : JAMIA|April 2, 2015
Recommendations to improve the usability of drug-drug interaction clinical decision support alertsThomas H Payne, Lisa E Hines, Raymond C Chan, et al.
Plos One|April 14, 2021
Mapping expanded prostate cancer index composite to EQ5D utilities to inform economic evaluations in prostate cancer: Secondary analysis of NRG/RTOG 0415Rahul Khairnar, Stephanie L Pugh, Howard M Sandler, et al.
The Lancet. Oncology|September 8, 2018
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic reviewMadeline Pe, Lien Dorme, Corneel Coens, et al.
The Lancet. Oncology|February 3, 2020
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL ConsortiumCorneel Coens, Madeline Pe, Amylou C Dueck, et al.
Clinical Trials (London, England)|August 25, 2018
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trialsAndrew Bottomley, Madeline Pe, Jeff Sloan, et al.
The Lancet. Oncology|November 8, 2016
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standardsAndrew Bottomley, Madeline Pe, Jeff Sloan, et al.
Lancet (London, England)|May 19, 2024
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trialChris C Parker, Howard Kynaston, Adrian D Cook, et al.
Lancet (London, England)|May 19, 2024
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trialChris C Parker, Noel W Clarke, Adrian D Cook, et al.
JAMIA Open|August 4, 2021
Establishing a multidisciplinary initiative for interoperable electronic health record innovations at an academic medical centerKensaku Kawamoto, Polina V Kukhareva, Charlene Weir, et al.
Pageof 78